ELF1_HUMAN - dbPTM
ELF1_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID ELF1_HUMAN
UniProt AC P32519
Protein Name ETS-related transcription factor Elf-1
Gene Name ELF1
Organism Homo sapiens (Human).
Sequence Length 619
Subcellular Localization Nucleus.
Protein Description Transcription factor that activates the LYN and BLK promoters. Appears to be required for the T-cell-receptor-mediated trans activation of HIV-2 gene expression. Binds specifically to two purine-rich motifs in the HIV-2 enhancer..
Protein Sequence MAAVVQQNDLVFEFASNVMEDERQLGDPAIFPAVIVEHVPGADILNSYAGLACVEEPNDMITESSLDVAEEEIIDDDDDDITLTVEASCHDGDETIETIEAAEALLNMDSPGPMLDEKRINNNIFSSPEDDMVVAPVTHVSVTLDGIPEVMETQQVQEKYADSPGASSPEQPKRKKGRKTKPPRPDSPATTPNISVKKKNKDGKGNTIYLWEFLLALLQDKATCPKYIKWTQREKGIFKLVDSKAVSRLWGKHKNKPDMNYETMGRALRYYYQRGILAKVEGQRLVYQFKEMPKDLIYINDEDPSSSIESSDPSLSSSATSNRNQTSRSRVSSSPGVKGGATTVLKPGNSKAAKPKDPVEVAQPSEVLRTVQPTQSPYPTQLFRTVHVVQPVQAVPEGEAARTSTMQDETLNSSVQSIRTIQAPTQVPVVVSPRNQQLHTVTLQTVPLTTVIASTDPSAGTGSQKFILQAIPSSQPMTVLKENVMLQSQKAGSPPSIVLGPAQVQQVLTSNVQTICNGTVSVASSPSFSATAPVVTFSPRSSQLVAHPPGTVITSVIKTQETKTLTQEVEKKESEDHLKENTEKTEQQPQPYVMVVSSSNGFTSQVAMKQNELLEPNSF
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
110PhosphorylationEALLNMDSPGPMLDE
HHHHCCCCCCCCCCH
22.4626074081
126PhosphorylationRINNNIFSSPEDDMV
HCCCCCCCCCCCCEE
40.9825627689
127PhosphorylationINNNIFSSPEDDMVV
CCCCCCCCCCCCEEE
22.8925627689
160PhosphorylationTQQVQEKYADSPGAS
HHHHHHHHCCCCCCC
18.1923927012
163PhosphorylationVQEKYADSPGASSPE
HHHHHCCCCCCCCCC
19.6429255136
167PhosphorylationYADSPGASSPEQPKR
HCCCCCCCCCCCCCC
52.9529255136
168PhosphorylationADSPGASSPEQPKRK
CCCCCCCCCCCCCCC
31.7429255136
180PhosphorylationKRKKGRKTKPPRPDS
CCCCCCCCCCCCCCC
47.6323927012
187PhosphorylationTKPPRPDSPATTPNI
CCCCCCCCCCCCCCE
21.0825159151
190PhosphorylationPRPDSPATTPNISVK
CCCCCCCCCCCEEEE
46.2825159151
191PhosphorylationRPDSPATTPNISVKK
CCCCCCCCCCEEEEE
19.2223401153
195PhosphorylationPATTPNISVKKKNKD
CCCCCCEEEEEECCC
34.2323401153
197UbiquitinationTTPNISVKKKNKDGK
CCCCEEEEEECCCCC
51.76-
226UbiquitinationQDKATCPKYIKWTQR
HCCCCCHHHCCCHHH
62.85-
229UbiquitinationATCPKYIKWTQREKG
CCCHHHCCCHHHCCC
40.89-
231PhosphorylationCPKYIKWTQREKGIF
CHHHCCCHHHCCCEE
16.8522817900
239UbiquitinationQREKGIFKLVDSKAV
HHCCCEEEEECHHHH
45.7621890473
239UbiquitinationQREKGIFKLVDSKAV
HHCCCEEEEECHHHH
45.7621890473
244UbiquitinationIFKLVDSKAVSRLWG
EEEEECHHHHHHHHC
48.63-
256UbiquitinationLWGKHKNKPDMNYET
HHCCCCCCCCCCHHH
47.39-
261PhosphorylationKNKPDMNYETMGRAL
CCCCCCCHHHHHHHH
13.21-
269MethylationETMGRALRYYYQRGI
HHHHHHHHHHHHCCC
19.20-
270PhosphorylationTMGRALRYYYQRGIL
HHHHHHHHHHHCCCC
13.8428270605
271PhosphorylationMGRALRYYYQRGILA
HHHHHHHHHHCCCCC
6.1628270605
272PhosphorylationGRALRYYYQRGILAK
HHHHHHHHHCCCCCE
5.2528270605
279SumoylationYQRGILAKVEGQRLV
HHCCCCCEEECCEEE
37.06-
279SumoylationYQRGILAKVEGQRLV
HHCCCCCEEECCEEE
37.06-
279UbiquitinationYQRGILAKVEGQRLV
HHCCCCCEEECCEEE
37.06-
290UbiquitinationQRLVYQFKEMPKDLI
CEEEEEEECCCCCEE
37.2621890473
290UbiquitinationQRLVYQFKEMPKDLI
CEEEEEEECCCCCEE
37.2621890473
305PhosphorylationYINDEDPSSSIESSD
EECCCCCCCCCCCCC
49.3827690223
306PhosphorylationINDEDPSSSIESSDP
ECCCCCCCCCCCCCC
40.5030576142
307PhosphorylationNDEDPSSSIESSDPS
CCCCCCCCCCCCCCC
34.4130576142
310PhosphorylationDPSSSIESSDPSLSS
CCCCCCCCCCCCCCC
38.0727690223
311PhosphorylationPSSSIESSDPSLSSS
CCCCCCCCCCCCCCC
40.5327690223
317PhosphorylationSSDPSLSSSATSNRN
CCCCCCCCCCCCCCC
29.3225627689
318PhosphorylationSDPSLSSSATSNRNQ
CCCCCCCCCCCCCCC
31.9925627689
329PhosphorylationNRNQTSRSRVSSSPG
CCCCCCCCHHCCCCC
36.4830576142
332PhosphorylationQTSRSRVSSSPGVKG
CCCCCHHCCCCCCCC
24.8026055452
333PhosphorylationTSRSRVSSSPGVKGG
CCCCHHCCCCCCCCC
37.3823401153
334PhosphorylationSRSRVSSSPGVKGGA
CCCHHCCCCCCCCCC
20.4026055452
342PhosphorylationPGVKGGATTVLKPGN
CCCCCCCEEEECCCC
22.2528122231
343PhosphorylationGVKGGATTVLKPGNS
CCCCCCEEEECCCCC
24.2528122231
346AcetylationGGATTVLKPGNSKAA
CCCEEEECCCCCCCC
46.6823749302
350PhosphorylationTVLKPGNSKAAKPKD
EEECCCCCCCCCCCC
29.5923312004
351AcetylationVLKPGNSKAAKPKDP
EECCCCCCCCCCCCC
57.2625953088
354AcetylationPGNSKAAKPKDPVEV
CCCCCCCCCCCCCCC
58.4225953088
354UbiquitinationPGNSKAAKPKDPVEV
CCCCCCCCCCCCCCC
58.42-
370PhosphorylationQPSEVLRTVQPTQSP
CHHHHHHCCCCCCCC
21.2328450419
374PhosphorylationVLRTVQPTQSPYPTQ
HHHCCCCCCCCCCCE
25.2928450419
376PhosphorylationRTVQPTQSPYPTQLF
HCCCCCCCCCCCEEE
28.9525159151
378PhosphorylationVQPTQSPYPTQLFRT
CCCCCCCCCCEEEEE
24.9428450419
380PhosphorylationPTQSPYPTQLFRTVH
CCCCCCCCEEEEEEE
31.8728450419
403O-linked_GlycosylationPEGEAARTSTMQDET
CCCCCCCCCCCCHHH
24.6730059200
404O-linked_GlycosylationEGEAARTSTMQDETL
CCCCCCCCCCCHHHH
19.1430059200
405O-linked_GlycosylationGEAARTSTMQDETLN
CCCCCCCCCCHHHHH
20.4530059200
406SulfoxidationEAARTSTMQDETLNS
CCCCCCCCCHHHHHH
4.7821406390
413O-linked_GlycosylationMQDETLNSSVQSIRT
CCHHHHHHHHHHHEE
34.6930059200
413PhosphorylationMQDETLNSSVQSIRT
CCHHHHHHHHHHHEE
34.6927251275
414PhosphorylationQDETLNSSVQSIRTI
CHHHHHHHHHHHEEE
24.0928555341
420PhosphorylationSSVQSIRTIQAPTQV
HHHHHHEEEECCCCC
18.7729396449
425PhosphorylationIRTIQAPTQVPVVVS
HEEEECCCCCCEEEC
45.2626657352
432PhosphorylationTQVPVVVSPRNQQLH
CCCCEEECCCCCEEE
13.4125159151
440PhosphorylationPRNQQLHTVTLQTVP
CCCCEEEEEEEEECC
24.6324043423
442PhosphorylationNQQLHTVTLQTVPLT
CCEEEEEEEEECCCE
17.8224043423
445PhosphorylationLHTVTLQTVPLTTVI
EEEEEEEECCCEEEE
27.4924043423
449PhosphorylationTLQTVPLTTVIASTD
EEEECCCEEEEEECC
16.9724043423
450PhosphorylationLQTVPLTTVIASTDP
EEECCCEEEEEECCC
20.0024043423
454PhosphorylationPLTTVIASTDPSAGT
CCEEEEEECCCCCCC
23.4024043423
455PhosphorylationLTTVIASTDPSAGTG
CEEEEEECCCCCCCC
42.7924043423
458PhosphorylationVIASTDPSAGTGSQK
EEEECCCCCCCCCCE
41.9824043423
461PhosphorylationSTDPSAGTGSQKFIL
ECCCCCCCCCCEEEE
33.1224043423
463PhosphorylationDPSAGTGSQKFILQA
CCCCCCCCCEEEEEE
29.9922817901
473O-linked_GlycosylationFILQAIPSSQPMTVL
EEEEECCCCCCCEEE
35.1830059200
473PhosphorylationFILQAIPSSQPMTVL
EEEEECCCCCCCEEE
35.1827251275
474O-linked_GlycosylationILQAIPSSQPMTVLK
EEEECCCCCCCEEEE
32.7130059200
474PhosphorylationILQAIPSSQPMTVLK
EEEECCCCCCCEEEE
32.7117525332
478O-linked_GlycosylationIPSSQPMTVLKENVM
CCCCCCCEEEEHHHH
29.3930059200
478PhosphorylationIPSSQPMTVLKENVM
CCCCCCCEEEEHHHH
29.3927251275
481UbiquitinationSQPMTVLKENVMLQS
CCCCEEEEHHHHHCC
42.79-
488O-linked_GlycosylationKENVMLQSQKAGSPP
EHHHHHCCCCCCCCC
29.6830059200
493O-linked_GlycosylationLQSQKAGSPPSIVLG
HCCCCCCCCCEEEEC
38.2030059200
509O-linked_GlycosylationAQVQQVLTSNVQTIC
HHHHHHHHCCCCEEE
21.2830059200
510O-linked_GlycosylationQVQQVLTSNVQTICN
HHHHHHHCCCCEEEC
30.7330059200
514O-linked_GlycosylationVLTSNVQTICNGTVS
HHHCCCCEEECCEEE
24.1830059200
519O-linked_GlycosylationVQTICNGTVSVASSP
CCEEECCEEEECCCC
8.8030059200
521O-linked_GlycosylationTICNGTVSVASSPSF
EEECCEEEECCCCCC
16.2930059200
525O-linked_GlycosylationGTVSVASSPSFSATA
CEEEECCCCCCCCCC
18.1530059200
527O-linked_GlycosylationVSVASSPSFSATAPV
EEECCCCCCCCCCCE
33.5130059200
529O-linked_GlycosylationVASSPSFSATAPVVT
ECCCCCCCCCCCEEE
29.1030059200
531O-linked_GlycosylationSSPSFSATAPVVTFS
CCCCCCCCCCEEEEC
30.2330059200
536O-linked_GlycosylationSATAPVVTFSPRSSQ
CCCCCEEEECCCHHH
20.7330059200
536PhosphorylationSATAPVVTFSPRSSQ
CCCCCEEEECCCHHH
20.7326074081
538PhosphorylationTAPVVTFSPRSSQLV
CCCEEEECCCHHHEE
15.2726074081
541PhosphorylationVVTFSPRSSQLVAHP
EEEECCCHHHEEECC
26.3126074081
542PhosphorylationVTFSPRSSQLVAHPP
EEECCCHHHEEECCC
28.9026074081
547 (in isoform 2)Ubiquitination-22.9320972266
554PhosphorylationHPPGTVITSVIKTQE
CCCCCEEEEEEECHH
16.7722210691
555PhosphorylationPPGTVITSVIKTQET
CCCCEEEEEEECHHC
15.6622210691
558AcetylationTVITSVIKTQETKTL
CEEEEEEECHHCHHH
41.8425953088
559PhosphorylationVITSVIKTQETKTLT
EEEEEEECHHCHHHH
22.10-
562PhosphorylationSVIKTQETKTLTQEV
EEEECHHCHHHHHHH
21.3622210691
564PhosphorylationIKTQETKTLTQEVEK
EECHHCHHHHHHHHH
42.3222210691
566PhosphorylationTQETKTLTQEVEKKE
CHHCHHHHHHHHHHH
28.1017525332
571UbiquitinationTLTQEVEKKESEDHL
HHHHHHHHHHCHHHH
68.002097226
618PhosphorylationNELLEPNSF------
CCCCCCCCC------
42.9430576142

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
-KUbiquitinationE3 ubiquitin ligasePJA1Q8NG27
PMID:22199232

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of ELF1_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of ELF1_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
NFKB1_HUMANNFKB1physical
7862168
REL_HUMANRELphysical
7862168
NFKB1_HUMANNFKB1physical
9094628
HXC13_HUMANHOXC13physical
18692240
HPBP1_HUMANHSPBP1physical
28514442

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of ELF1_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-160; SER-163; SER-167;SER-187 AND SER-432, AND MASS SPECTROMETRY.
"Large-scale proteomics analysis of the human kinome.";
Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.;
Mol. Cell. Proteomics 8:1751-1764(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-167, AND MASSSPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-160; SER-163 ANDSER-168, AND MASS SPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-163; SER-168 ANDSER-432, AND MASS SPECTROMETRY.
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis.";
Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III;
J. Proteome Res. 7:1346-1351(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-432, AND MASSSPECTROMETRY.
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage.";
Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
Science 316:1160-1166(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-474 AND THR-566, ANDMASS SPECTROMETRY.
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization.";
Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
Nat. Biotechnol. 24:1285-1292(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-432, AND MASSSPECTROMETRY.
"Large-scale characterization of HeLa cell nuclear phosphoproteins.";
Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-168, AND MASSSPECTROMETRY.

TOP